Business Wire
BusinessEli Lilly rumored to be nearing a deal for psychedelic drug developer AtaiBeckley, shares jumpThe Apex TimesBusinessGH Research jumps as traders price in reports of a possible Eli Lilly-Atai Life Sciences dealThe Apex TimesBusinessNvidia boosts AI and robotics ties with major Japanese manufacturers, adding new partner announcementsThe Apex TimesBusinessUnitedHealth tops expectations, lifts full-year outlook in latest earnings reportThe Apex TimesBusinessGE Aerospace posts higher-than-expected profit and revenue, but shares fall after upbeat updateThe Apex TimesBusinessUber reaches agreement to acquire Delivery Hero in $14.8 billion deal aimed at scaling international food deliveryThe Apex TimesBusinessAT&T brings fan experiences to Fanatics Fest NYC at the Javits Center this weekThe Apex TimesBusinessModerna starts first dosing in U.S. Phase 1 trial of tumor-targeted mRNA-4200 cancer antigen therapyThe Apex TimesBusinessBuffett comment sparks renewed focus on how Berkshire weighs Alphabet against other holdingsThe Apex TimesBusinessGE Aerospace slips as investors weigh resilient earnings against a broader AI-driven risk-off moodThe Apex TimesBusinessEli Lilly to buy psychedelic-focused AtaiBeckley for $2.8 billion, aiming for a DMT-based treatment for resistant depressionThe Apex TimesBusinessCostco’s strong 5-year run faces fresh valuation scrutiny as stock screens “expensive” on broad checksThe Apex TimesBusinessEli Lilly rumored to be nearing a deal for psychedelic drug developer AtaiBeckley, shares jumpThe Apex TimesBusinessGH Research jumps as traders price in reports of a possible Eli Lilly-Atai Life Sciences dealThe Apex TimesBusinessNvidia boosts AI and robotics ties with major Japanese manufacturers, adding new partner announcementsThe Apex TimesBusinessUnitedHealth tops expectations, lifts full-year outlook in latest earnings reportThe Apex TimesBusinessGE Aerospace posts higher-than-expected profit and revenue, but shares fall after upbeat updateThe Apex TimesBusinessUber reaches agreement to acquire Delivery Hero in $14.8 billion deal aimed at scaling international food deliveryThe Apex TimesBusinessAT&T brings fan experiences to Fanatics Fest NYC at the Javits Center this weekThe Apex TimesBusinessModerna starts first dosing in U.S. Phase 1 trial of tumor-targeted mRNA-4200 cancer antigen therapyThe Apex TimesBusinessBuffett comment sparks renewed focus on how Berkshire weighs Alphabet against other holdingsThe Apex TimesBusinessGE Aerospace slips as investors weigh resilient earnings against a broader AI-driven risk-off moodThe Apex TimesBusinessEli Lilly to buy psychedelic-focused AtaiBeckley for $2.8 billion, aiming for a DMT-based treatment for resistant depressionThe Apex TimesBusinessCostco’s strong 5-year run faces fresh valuation scrutiny as stock screens “expensive” on broad checksThe Apex TimesBusinessEli Lilly rumored to be nearing a deal for psychedelic drug developer AtaiBeckley, shares jumpThe Apex TimesBusinessGH Research jumps as traders price in reports of a possible Eli Lilly-Atai Life Sciences dealThe Apex TimesBusinessNvidia boosts AI and robotics ties with major Japanese manufacturers, adding new partner announcementsThe Apex TimesBusinessUnitedHealth tops expectations, lifts full-year outlook in latest earnings reportThe Apex TimesBusinessGE Aerospace posts higher-than-expected profit and revenue, but shares fall after upbeat updateThe Apex TimesBusinessUber reaches agreement to acquire Delivery Hero in $14.8 billion deal aimed at scaling international food deliveryThe Apex TimesBusinessAT&T brings fan experiences to Fanatics Fest NYC at the Javits Center this weekThe Apex TimesBusinessModerna starts first dosing in U.S. Phase 1 trial of tumor-targeted mRNA-4200 cancer antigen therapyThe Apex TimesBusinessBuffett comment sparks renewed focus on how Berkshire weighs Alphabet against other holdingsThe Apex TimesBusinessGE Aerospace slips as investors weigh resilient earnings against a broader AI-driven risk-off moodThe Apex TimesBusinessEli Lilly to buy psychedelic-focused AtaiBeckley for $2.8 billion, aiming for a DMT-based treatment for resistant depressionThe Apex TimesBusinessCostco’s strong 5-year run faces fresh valuation scrutiny as stock screens “expensive” on broad checksThe Apex TimesBusinessEli Lilly rumored to be nearing a deal for psychedelic drug developer AtaiBeckley, shares jumpThe Apex TimesBusinessGH Research jumps as traders price in reports of a possible Eli Lilly-Atai Life Sciences dealThe Apex TimesBusinessNvidia boosts AI and robotics ties with major Japanese manufacturers, adding new partner announcementsThe Apex TimesBusinessUnitedHealth tops expectations, lifts full-year outlook in latest earnings reportThe Apex TimesBusinessGE Aerospace posts higher-than-expected profit and revenue, but shares fall after upbeat updateThe Apex TimesBusinessUber reaches agreement to acquire Delivery Hero in $14.8 billion deal aimed at scaling international food deliveryThe Apex TimesBusinessAT&T brings fan experiences to Fanatics Fest NYC at the Javits Center this weekThe Apex TimesBusinessModerna starts first dosing in U.S. Phase 1 trial of tumor-targeted mRNA-4200 cancer antigen therapyThe Apex TimesBusinessBuffett comment sparks renewed focus on how Berkshire weighs Alphabet against other holdingsThe Apex TimesBusinessGE Aerospace slips as investors weigh resilient earnings against a broader AI-driven risk-off moodThe Apex TimesBusinessEli Lilly to buy psychedelic-focused AtaiBeckley for $2.8 billion, aiming for a DMT-based treatment for resistant depressionThe Apex TimesBusinessCostco’s strong 5-year run faces fresh valuation scrutiny as stock screens “expensive” on broad checksThe Apex Times
Back to front
Report ties Greg Abel’s Berkshire legacy to Alphabet as Buffett’s successor steers big tech bets
The Apex Times

THE APEX TIMES

Business/The Apex Times/Jul 16, 6:09 AM EDT

Report ties Greg Abel’s Berkshire legacy to Alphabet as Buffett’s successor steers big tech bets

A market commentary published July 16 points to Berkshire Hathaway’s deep exposure to major technology companies, including Alphabet, and argues investors should consider a more defensive posture. It also spotlights Greg Abel’s role as a hand-picked successor to Warren Buffett.

3 min readEditor-approved Apex article

A July 16 market commentary highlighted how Berkshire Hathaway’s concentrated equity positions continue to shape the fortunes of its most closely watched managers, drawing attention to Greg Abel, Warren Buffett’s designated successor. The piece argues that Abel, often described as the successor Buffett has built to take over the conglomerate’s leadership, has steered or upheld portfolio exposure that includes large stakes in Apple and Alphabet, with the author estimating that the two holdings account for roughly 30% of Berkshire’s portfolio.

The article’s central claim is about concentration. It frames Berkshire’s approach not as broad indexing across many sectors, but as a set of major bets in recognizable consumer and technology franchises. In that context, Alphabet is presented as one of the scale names Berkshire already owns, meaning Alphabet’s share price performance remains linked, at least indirectly, to Berkshire’s investment priorities and to how investors interpret the handoff to Abel.

Although the commentary emphasizes Alphabet, it does not appear to provide new corporate disclosures from Alphabet itself or from Berkshire in the material referenced here. Instead, it draws on the composition of Berkshire’s public holdings and on the narrative of leadership transition. The implication for Alphabet shareholders is that a major shareholder’s direction can become part of the stock’s investor story, even when Alphabet’s own business operations are unchanged.

The same commentary also mentions “an under-the-radar” Berkshire stock it calls a top pick for July, and it characterizes the broader moment as an “opportunity to get defensive.” That framing suggests the author believes risks are rising or that valuations and economic uncertainty favor select, non-consensus holdings. However, because the specific Berkshire ticker and the reasoning details are not included in the available information here, those claims cannot be verified or elaborated beyond what the headline indicates.

From Alphabet’s standpoint, the most immediate link is straightforward: the company is a member of the investor attention pool because Berkshire is a widely followed owner of its stock. When big managers are in focus, markets often pay closer attention to whether leadership changes could alter the risk profile of future purchases, rebalancing cadence, or the sector mix of new investments. For Alphabet, that matters less for day-to-day fundamentals and more for sentiment around ownership and long-term commitment.

There is, however, a meaningful limitation in what can be concluded from this specific item. The claims about Abel’s portfolio impact and the estimate that Apple plus Alphabet represent about 30% of Berkshire’s portfolio are editorial assertions tied to the commentary’s interpretation. Without direct excerpts from Berkshire’s filings, investor letters, or a detailed breakdown of the portfolio percentages referenced in the piece, readers should treat those numbers as author-reported rather than company-verified metrics.

What to watch next is whether additional, primary-source Berkshire communications shed light on how Abel views the next phase of the conglomerate’s stock investing. Market participants may also look for signs in future filings that could confirm the size of Alphabet’s position within Berkshire’s portfolio and whether the firm’s exposure to large-cap technology remains a steady feature or becomes more selective as conditions evolve.

Why It Matters

  • Big, widely held positions can become catalysts for investor attention, even when the underlying operating outlook of the company has not changed.
  • Leadership transitions at influential investors can affect market expectations about future risk tolerance and sector concentration.
  • Alphabet’s stock can be influenced by how investors anticipate Berkshire’s continued commitment to large-cap technology.
  • The “defensive” framing indicates heightened focus on portfolio composition and valuation discipline among equity investors.

Sources

Key Facts

  • A July 16 market commentary described Greg Abel as Warren Buffett’s hand-picked successor and discussed Abel’s role in Berkshire Hathaway’s leadership transition.
  • The commentary claims that Apple and Alphabet together represent about 30% of Berkshire Hathaway’s portfolio.
  • The commentary also described Berkshire’s holdings as part of a more defensive investing posture for July.
  • Alphabet was singled out by name as one of the large companies tied to Berkshire’s portfolio exposure in the commentary.
  • The item referenced does not provide additional primary-source details about Berkshire’s transactions or Alphabet’s own disclosures in the information available here.

Technology Related